You May Also Like

Eli Lilly close to buying gene editing firm Verve for $1.3 bln- FT

US and UK announce a trade deal, but steel imports unresolved

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

TSX ended higher amid G7 summit, Israel-Iran tensions

OpenAI executives have discussed accusing Microsoft of anticompetitive behavior, WSJ reports

Wells Fargo upgrades Wix as it sees scope for price increases